Alcidion Group Limited (ASX: ALC) - ETF Exposure

Current share price for ALC : $0.105 0.005 (5%)⁺

Alcidion Group Limited (ALC) is an ASX-listed company and is held by a number of exchange traded funds (ETFs). It is a Company that is engaged in the development and licensing of its healthcare software products (Miya Precision and its associated modules, including Miya Observations, Flow, Task Management and PAS), the reselling of selected healthcare software products from its partners and the delivery of product implementation, product support and maintenance, systems integration and data analysis services to healthcare customers in Australia, New Zealand and the United Kingdom.

ALC General Information ⁺

ASX Code	ALC
Website	http://www.alcidion.com
Industry/Sector	Health Care Technology
Market Cap ($M)	141
ALC Share Price	$0.105
Day High	$0.105
Day Low	$0.100
Last Close	$0.100
ALC Share Price Movement	$0.00 ( 5% )

Prices as at 16:40, 10 Sep 2026

⁺Security prices are delayed by at least 20 minutes and are indicative only.

Already own an Australian ETF? You may already have meaningful exposure to ALC

Alcidion Group Limited (ALC) is held across 1 ETF spanning strategies that include health care technology exposure . Its weighting in those funds means performance can have an outsized influence - when ALC moves, funds like DACE that hold it can move with it.

For more concentrated exposure, ETFs such as DACE (Dimensional Australian Core Equity (Managed Fund)) allocate about 0% to ALC , while the average exposure across all 1 ETF that hold it is around 0% .

Top ETF holdings

Dimensional Australian Core Equity (Managed Fund) (DACE) ~ 0%

Last updated: ETF data and holdings as at 10 September 2026

Own ALC directly or through an ETF?

How does holding Alcidion Group Limited (ALC) shares directly compare to ETFs that include it?

	ALC Direct	DACE ASX
Holdings	1 company	485 holdings
ALC Weight	100%	0%
Diversification	Single Stock	Broad
Annual Cost	Brokerage only	0.28% p.a.
Approx. Yield	0%	3%
Star Ratings	-

Yields and costs are approximate. ETF yields reflect the fund's dividend distributions, not ALC's direct yield. Annual cost uses each ETF's MER.

ALC Exposure on $10,000 investment

How a $10,000 investment in Alcidion Group Limited (ALC) one week ago compares with ETFs that hold it.

Security	Investment type	Current price	7-day price movement	Dollar change	Value today
Alcidion Group Limited (ALC)	Direct share	$0.105	8.25%	+$825	$10,825
Dimensional Australian Core Equity (Managed Fund) (DACE)	Equity - Australia Strategy	$19.040	-0.99%	-$99	$9,901

Assumes $10,000 invested 7 days ago. Figures are based on price movement only and exclude distributions, fees and brokerage.

Alcidion Group Limited (ALC) ETFs

1 ETF hold Alcidion Group Limited (ALC).

ETF	ALC Weight	MER	Yield
Dimensional Australian Core Equity (Managed Fund) (DACE)	0%	0.28%	3%

Alcidion Group Limited (ALC) Upcoming Dividends & Yields

Distribution Type	Dividend	Franking	Ex-dividend date	Payment date	Current Price⁺	Price 7D Avg	Dividend Yield

See all dividends from Alcidion Group Limited (ALC) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Alcidion Group Limited (ALC) price-sensitive announcements

ALC - FY26 Results Presentation

Alcidion Group Limited's FY26 results show strong financial performance with a 27% increas

Alcidion Group Limited (ALC)
19 Aug 2026 | 8:00 AM

ALC - FY26 Results Release

Alcidion Group Limited reported a strong financial performance for FY26, with a revenue in

Alcidion Group Limited (ALC)
19 Aug 2026 | 8:00 AM

ALC - FY26 Appendix 4E and Annual Report

The FY26 Annual Report of Alcidion Group Limited highlights a strong financial and operati

Alcidion Group Limited (ALC)
19 Aug 2026 | 7:58 AM

ALC - Q4 FY26 Quarterly Activities Report and Appendix 4C

In its Q4 FY26 report, Alcidion Group Limited achieved a record positive operating cash fl

Alcidion Group Limited (ALC)
23 Jul 2026 | 8:27 AM

Alcidion Group Limited (ALC) Recent ASX Announcements

Company	Sector	Market Cap ($m)	Headline	Release date/time⁺	Price at release⁺	Current price⁺	Gain/Loss
Alcidion Group Limited (ALC) ORDINARY FULLY PAID	Health Care	$142	Application for quotation of securities - ALC	4 Sep 2026 8:17AM	$0.098	$0.105	risen by 7.69%
Alcidion Group Limited (ALC) ORDINARY FULLY PAID	Health Care	$142	Relief from Quarterly Reporting	3 Sep 2026 11:56AM	$0.097	$0.105	risen by 8.25%
Alcidion Group Limited (ALC) ORDINARY FULLY PAID	Health Care	$142	Change of Director's Interest Notice	28 Aug 2026 8:16AM	$0.096	$0.105	risen by 9.37%
Alcidion Group Limited (ALC) ORDINARY FULLY PAID	Health Care	$142	Change of Director's Interest Notice	27 Aug 2026 9:31AM	$0.093	$0.105	risen by 12.90%
Alcidion Group Limited (ALC) ORDINARY FULLY PAID	Health Care	$142	Change in substantial holding	24 Aug 2026 4:26PM	$0.094	$0.105	risen by 11.70%
Alcidion Group Limited (ALC) ORDINARY FULLY PAID	Health Care	$142	FY26 Corporate Governance Statement	19 Aug 2026 8:01AM	$0.087	$0.105	risen by 20.69%

ALC Financial Summary

Year to Jun	NPAT	EPS	EPS chg (%)	PER	Yield (%)	Franking (%)
2028F	C2	$10.80	31.90%	1.00	0.00%	0.0%
2027F	C2	$8.20	3,975.00%	1.30	0.00%	0.0%
2026A	$2.70	$0.20	66.70%	51.80	0.00%	0.0%

ALC Peer Comparison

Company	Mkt Cap	EPS Growth (%)			P/E (%)			Dividend Yield (%)
Company	Mkt Cap	2026 A	2027 F	2028 F	2026 A	2027 F	2028 F	2026 A	2027 F	2028 F
4DMedical Limited (4DX)	$2,081M	1.4982	0.0000	0.0000	0.0000	0.0000	0.0000	0.00%	0.00%	0.00%
Alcidion Group Limited (ALC)	$135M	0.6667	39.7500	0.3190	50.0000	1.2270	0.9302	0.00%	0.00%	0.00%
Pro Medicus Limited (PME)	$17,395M	1.3034	-0.2811	0.2395	65.6585	91.3334	73.6835	0.41%	0.56%	0.69%

ALC Market Comparison

	Earnings	P/E Ratio	P/B Ratio	P/E Growth
Company	0.42	5.94	1.55	0.01
Market	0.34	13.60	1.17	0.80
Sector	0.62	19.40	1.99	2.58

ALC Directors

Name	Position	Start Date
Ms Katrina (Kate) Elizabeth Doyle (Quirke)	Chief Executive Officer, Executive Director, Managing Director	3 Jul 2018
Mr William (Bill) Smart	Non-Executive Director	1 Oct 2024
Mr Daniel Sharp	Non-Executive Director	1 Sep 2021
Professor Andrew Way	Non-Executive Director	15 Apr 2025
Ms Rebecca Jayne Wilson	Non-Executive Director, Non-Executive Chairman	31 Jul 2017

Alcidion Group Limited (ALC) Changes in Directors' Interest & Trades

Date of change	Director	Buy/Sell	Security Type	Qty	Trade Price	Value
26 Aug 2026	WAY, Andrew	Buy	Direct Shares	107,526	$0.093	$9,999.918
26 Aug 2026	WAY, Andrew	Buy	Direct Shares	107,526	$0.093	$9,999.918
24 Aug 2026	WAY, Andrew	Buy	Direct Shares	107,526	$0.093	$9,999.918

See all changes in directors' interest & trades for Alcidion Group Limited (ALC) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

ALC Management

Name	Position
Matthew Gepp	Chief Financial Officer
Michael Sapountzis	Company Secretary

ALC Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Alcidion Group Limited (ALC). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding	Name
153,116,042 (11.40%)	AustralianSuper Pty Limited
116,416,160 (8.67%)	Malcolm Pradhan
68,664,657 (5.11%)	Raymond Howard Blight

ALC Calendar of Events

Date	Event
18 August 2027	Report (Annual)
18 August 2027	Report (Prelim)
25 February 2027	Report (Interim)
12 November 2026	AGM

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.

What our members say about us